Ferric maltoll, sold under the brand names Accrufer and Feraccru, is for the treatment of adults with low iron stores. Ferric maltol (ST10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Ferric maltol can cause serious side effects including increased risk of inflammatory bowel disease flare and iron overload in the body.
Mukha, S. A.; Antipova, I. A.; Medvedeva, S. A.; Saraev, V. V.; Larina, L. I.; Tsyrenzhapov, A. V.; Sukhov, B. G. Synthesis and properties of metal chelates from natural γ-pyrone maltol. Khimiya v Interesakh Ustoichivogo Razvitiya. Volume 15. Issue 4. Pages 457-466. Journal. (2007).
Powell, Jonathan Joseph; Faria, Nuno Jorge Rodrigues. Methods for producing ferric maltol compositions from ferrous hydroxides. Assignee Medical Research Council, UK. WO 2017167970. (2017).
Powell, Jonathan Joseph; Faria, Nuno Jorge Rodrigues. Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides. Assignee Medical Research Council, UK. WO 2017167963. (2017).
Childs, David Paul. Crystalline polymorphic forms of ferric maltol. Assignee Iron Therapeutics Holdings AG, Switz. WO 2016066555. (2016).
